Middle East And Africa Nucleic Acid Isolation Purification Market
Taille du marché en milliards USD
TCAC :
% 
USD
225.03 Million
USD
396.75 Million
2024
2032
 Période de prévision |
2025 –2032 |
 Taille du marché (année de référence) |
USD 225.03 Million |
 Taille du marché (année de prévision) |
USD 396.75 Million |
 TCAC |
% |
| Principaux acteurs du marché |
|
Marché de l'isolement et de la purification des acides nucléiques au Moyen-Orient et en Afrique, par produit (instruments, kits et réactifs), méthode (isolement et purification par billes magnétiques, isolement et purification sur colonne, isolement et purification par réactifs, etc.), type (séquençage de nouvelle génération (NGS), isolement et purification d'ADN génomique, isolement et purification d'ARN total, purification par PCR, isolement et purification d'ADN plasmidique, isolement et purification d'ARN messager, isolement et purification d'acides nucléiques circulants, isolement et purification de microARN, etc.), application (diagnostic, découverte et développement de médicaments, médecine personnalisée, agriculture et recherche animale, etc.), type d'échantillon (échantillons FFPE, cellules sanguines, bactéries, levures et plantes, échantillons acellulaires, cellules cultivées, cellules de mammifères, tissus cérébraux et rénaux, etc.), utilisateur final (hôpitaux) et centres de diagnostic, sociétés pharmaceutiques et biotechnologiques, organismes de recherche sous contrat et organisations de développement et de fabrication sous contrat (CDMO), instituts universitaires/de recherche et autres) Tendances et prévisions de l'industrie jusqu'en 2032
Taille du marché de l'isolement et de la purification des acides nucléiques
- Le marché de l'isolement et de la purification des acides nucléiques au Moyen-Orient et en Afrique était évalué à 225,02 millions USD en 2024 et devrait atteindre 396,75 millions USD d'ici 2032.
- Au cours de la période de prévision de 2025 à 2032, le marché devrait croître à un TCAC de 8,0 %, principalement grâce au lancement prévu de nouveaux dispositifs de traitement.
- Cette croissance est due à des facteurs tels que la prévalence croissante des troubles génétiques, en particulier dans les pays en développement, qui entraîne une demande croissante de tests de diagnostic.
Analyse d'isolement et de purification des acides nucléiques
- La demande croissante de diagnostics basés sur l'acide nucléique, de médecine personnalisée et de recherche biopharmaceutique a considérablement accru le besoin de technologies efficaces d'isolement et de purification des acides nucléiques.
- De plus, les progrès en matière d'automatisation, de séparation par billes magnétiques et de plateformes microfluidiques améliorent la vitesse, le rendement et la précision de l'extraction des acides nucléiques, prenant en charge les applications à haut débit dans les contextes cliniques et de recherche.
- Par exemple, le marché de l'isolement et de la purification des acides nucléiques connaît une croissance notable dans des régions comme l'Asie-Pacifique, où l'expansion des secteurs biotechnologiques et l'augmentation du financement de la R&D accélèrent l'adoption de la technologie.
- En conclusion, la convergence des domaines d’application en pleine croissance et l’innovation continue dans les techniques d’isolement favorisent une forte expansion du marché, permettant d’améliorer les diagnostics moléculaires, la découverte de médicaments et la recherche génomique à l’échelle mondiale.
Portée du rapport et segmentation de l'isolement et de la purification des acides nucléiques
|
Attributs |
Informations clés sur le marché de l'isolement et de la purification des acides nucléiques |
|
Segments couverts |
|
|
Pays couverts |
|
|
Principaux acteurs du marché |
|
|
Opportunités de marché |
|
|
Ensembles d'informations de données à valeur ajoutée |
Outre les informations sur les scénarios de marché tels que la valeur marchande, le taux de croissance, la segmentation, la couverture géographique et les principaux acteurs, les rapports de marché organisés par Data Bridge Market Research comprennent également une analyse des importations et des exportations, un aperçu de la capacité de production, une analyse de la consommation de production, une analyse des tendances des prix, un scénario de changement climatique, une analyse de la chaîne d'approvisionnement, une analyse de la chaîne de valeur, un aperçu des matières premières/consommables, des critères de sélection des fournisseurs, une analyse PESTLE, une analyse Porter et un cadre réglementaire. |
Tendances du marché de l'isolement et de la purification des acides nucléiques
« Applications croissantes de la biopsie liquide dans le diagnostic non invasif »
- La biopsie liquide, qui analyse les acides nucléiques circulants (ADN, ARN, exosomes) dans les fluides corporels tels que le sang, permet la détection précoce, le suivi et le traitement personnalisé de diverses maladies, notamment le cancer.
- La complexité de l’extraction d’acides nucléiques de haute qualité à partir de ces échantillons divers et souvent fragmentés nécessite des technologies avancées d’isolement et de purification.
- Par exemple , la biopsie liquide, associée aux technologies omiques à haut débit, transforme la prise en charge des maladies grâce à des diagnostics non invasifs et personnalisés. Son utilisation croissante dans divers biofluides et son intégration en pratique clinique soulignent son utilité croissante. La standardisation, l'amélioration des protocoles et la découverte de biomarqueurs stimulent les progrès de la purification des acides nucléiques, permettant des soins plus précis, accessibles et individualisés.
- L’essor de la biopsie liquide en tant qu’outil de diagnostic non invasif offre des opportunités importantes pour le marché de l’isolement et de la purification des acides nucléiques.
- La biopsie liquide étant de plus en plus utilisée pour la détection précoce des maladies et le suivi des traitements, il existe un besoin croissant de technologies de purification avancées capables d'extraire des acides nucléiques de haute qualité à partir de fluides biologiques complexes.
Dynamique du marché de l'isolement et de la purification des acides nucléiques
Conducteur
« Augmentation des investissements dans la recherche en génomique »
- L’afflux de financement provenant des gouvernements, du secteur privé et des institutions de recherche du monde entier a intensifié le besoin d’un isolement d’acide nucléique fiable et de haute qualité pour soutenir les projets de séquençage à grande échelle, l’édition de gènes, la découverte de biomarqueurs et les initiatives de médecine personnalisée.
- Cet investissement stimule la demande de systèmes de purification efficaces et précis qui garantissent que les échantillons d'ADN et d'ARN répondent à la qualité requise pour des applications avancées telles que CRISPR, le séquençage de nouvelle génération (NGS) et d'autres outils génomiques.
- À mesure que la recherche se développe, le besoin de méthodes d'isolement évolutives et à haut débit augmente également, renforçant la croissance du marché et stimulant l'innovation dans les technologies de purification des acides nucléiques.
Par exemple,
- En décembre 2022, selon le BMJ, le gouvernement prévoyait d'investir plus de 190,54 millions de dollars dans l'amélioration du diagnostic des maladies génétiques rares chez les nouveau-nés, dans le diagnostic du cancer et dans la lutte contre les inégalités de santé, dans le cadre de son plan triennal. L'augmentation des investissements s'accompagne d'innovations dans ce domaine, moteurs de croissance du marché.
- En septembre 2023, selon le NHGRI, l'Institut national de recherche sur le génome humain (NHGRI) accélère la recherche en génomique en finançant et en collaborant avec des scientifiques d'institutions gouvernementales, publiques et privées. Grâce à des initiatives comme le programme de recherche « All of Us » et ENCODE, le NHGRI soutient la recherche sur les variations génétiques et leur impact sur la santé. Les partenariats s'étendent aux avancées technologiques en matière de séquençage et d'analyse de données, améliorant ainsi les outils génomiques et le partage des connaissances. Cette approche collaborative vise à favoriser les avancées en médecine de précision et en santé publique.
- L'augmentation des investissements dans la recherche en génomique propulse le marché de l'isolement et de la purification des acides nucléiques, car davantage de financement soutient les études génétiques avancées et le développement de traitements ciblés.
- Cette demande de purification d'ADN et d'ARN de haute qualité augmente avec des applications étendues comme NGS et CRISPR, créant un besoin de solutions d'isolement évolutives et efficaces pour soutenir la génomique de pointe.
Opportunité
« Augmentation des progrès technologiques et de l'automatisation »
- Les innovations technologiques telles que les systèmes d’extraction entièrement automatisés, le séquençage à haut débit et la microfluidique améliorent la précision, la rapidité et l’évolutivité de la recherche et du diagnostic génétiques.
- En réduisant les interventions manuelles, ces avancées minimisent les erreurs humaines et améliorent la cohérence du traitement des échantillons. Elles répondent à la demande croissante en génomique, protéomique et médecine personnalisée en permettant aux laboratoires de traiter des volumes d'échantillons plus importants avec précision et efficacité.
Par exemple,
- En décembre 2023, conformément à Technology Networks, Thermo Fisher Scientific Inc., leader mondial des services scientifiques, a lancé le Thermo Scientific KingFisher Apex Dx, un instrument automatisé de purification d'acides nucléiques, ainsi que le kit d'isolement d'acides nucléiques viraux/pathogènes MagMAX Dx d'Applied Biosystems. Ces produits fonctionnent ensemble pour permettre l'isolement et la purification d'agents pathogènes viraux et bactériens à partir d'échantillons respiratoires. Conçues pour être conformes aux normes de diagnostic in vitro (DIV) et de réglementation en matière de diagnostic in vitro (DIV-R), ces solutions automatisées offrent aux laboratoires une fiabilité accrue pour les résultats des analyses en aval.
- En novembre 2023, Elsevier a souligné que le développement de dispositifs automatisés d'extraction et de purification d'ARN/ADN pour le diagnostic des maladies infectieuses représente une avancée majeure en biotechnologie, soulignant l'essor des innovations technologiques et de l'automatisation dans ce domaine. Ces dispositifs rationalisent les flux de travail complexes des laboratoires, permettant un traitement rapide et précis des échantillons, essentiel à un diagnostic précis, notamment lors d'épidémies. Les avancées technologiques ont permis de créer des systèmes plus compacts, plus efficaces et plus conviviaux, réduisant les interventions manuelles et améliorant le rendement et la fiabilité. L'automatisation minimise non seulement les erreurs, mais accélère également les processus de diagnostic, favorisant ainsi des décisions cliniques rapides et améliorant les résultats pour les patients. L'intégration de ces technologies avancées transforme les diagnostics, les rendant plus accessibles, évolutifs et adaptables à divers contextes de soins.
- Les progrès rapides de la technologie et de l'automatisation transforment le marché de l'isolement et de la purification des acides nucléiques en améliorant la précision, l'efficacité et l'intégration avec les processus en aval.
- Ces innovations permettent aux laboratoires de répondre à la demande croissante en génomique, diagnostic et médecine personnalisée, avec des cadences plus élevées et des coûts réduits. À mesure que ces technologies se démocratisent, elles élargissent les capacités de recherche et de diagnostic, favorisant leur adoption par les laboratoires et les institutions du monde entier, accélérant ainsi les progrès dans de nombreux domaines scientifiques et médicaux.
Retenue/Défi
« Difficultés techniques dans l'isolement des acides nucléiques dans différents types d'échantillons »
- Différentes sources d’échantillons, telles que le sang, les tissus, l’urine et la salive, présentent des défis uniques en raison des différents niveaux de concentrations d’acides nucléiques, de la présence d’inhibiteurs et de la complexité de la matrice biologique.
- Les échantillons de sang peuvent contenir de faibles quantités d'ADN ou d'ARN libre circulant, tandis que les échantillons de tissus peuvent être plus difficiles en raison des niveaux élevés de contaminants et de composants cellulaires qui interfèrent avec l'extraction d'acide nucléique.
- De plus, certains échantillons, comme ceux provenant de tissus fixés au formol et inclus en paraffine, nécessitent des méthodes spécialisées pour empêcher la dégradation ou la perte d'acides nucléiques pendant le processus d'isolement.
Par exemple,
- En septembre 2020, un article publié par APOS indiquait que les échantillons biologiques tels que la salive ou l'urine contiennent de faibles concentrations d'acides nucléiques, nécessitant des protocoles très sensibles pour garantir une extraction précise. Les tissus, en particulier ceux riches en protéines ou en lipides, présentent souvent des difficultés pour séparer les acides nucléiques purs sans contamination. De plus, les échantillons comme les tissus FFPE sont soumis à une fixation au formol, ce qui réticule les acides nucléiques et complique l'extraction. Cependant, surmonter la complexité inhérente aux différents types d'échantillons reste un objectif essentiel pour les développements futurs, afin de garantir que les méthodes d'extraction et d'isolement des acides nucléiques soient adaptables, efficaces et évolutives pour un large éventail d'applications cliniques et de recherche.
- En septembre 2020, conformément à la directive, les matrices d'échantillons complexes contiennent souvent des inhibiteurs qui interfèrent avec l'amplification des acides nucléiques, réduisant ainsi la sensibilité et la fiabilité des tests. Des méthodes de lyse et d'extraction efficaces doivent éviter ces inhibiteurs tout en restant compatibles avec des flux de travail simplifiés. Trouver le juste équilibre entre performance et portabilité est essentiel pour adapter les procédés de purification des acides nucléiques à des plateformes de diagnostic sur le terrain et au point de service.
- Les défis techniques liés à l’isolement des acides nucléiques à partir de divers types d’échantillons, tels que le sang, les tissus et l’urine, créent des obstacles sur le marché de la purification des acides nucléiques.
- Ces échantillons présentent souvent de faibles rendements en acides nucléiques, des inhibiteurs ou des matrices biologiques complexes, nécessitant des méthodes spécialisées pour une extraction efficace
Portée du marché de l'isolement et de la purification des acides nucléiques au Moyen-Orient et en Afrique
Le marché de l'isolement et de la purification des acides nucléiques au Moyen-Orient et en Afrique est classé en cinq segments notables en fonction du produit, de la méthode, du type, du type d'échantillon et de l'utilisateur final.
|
Segmentation |
Sous-segmentation |
|
PAR PRODUIT |
|
|
PAR MÉTHODE |
|
|
PAR TYPE |
|
|
PAR TYPE D'ÉCHANTILLON |
|
|
PAR UTILISATEUR FINAL |
|
Analyse régionale du marché de l'isolement et de la purification des acides nucléiques au Moyen-Orient et en Afrique
« L'Afrique du Sud est le pays dominant sur le marché de l'isolement et de la purification des acides nucléiques »
- L’Afrique du Sud est la région dominante sur le marché de l’isolement et de la purification des acides nucléiques en raison de ses secteurs biotechnologique et pharmaceutique solides, soutenus par une infrastructure de recherche et développement robuste.
- En outre, la présence d’acteurs majeurs du marché et d’institutions de recherche en Afrique du Sud favorise l’innovation et les progrès dans les technologies d’isolement et de purification des acides nucléiques.
- De plus, les investissements importants dans la recherche génomique et la médecine de précision contribuent à la demande de solutions avancées d’extraction et de purification d’acides nucléiques en Afrique du Sud.
« L'Afrique du Sud devrait enregistrer le TCAC le plus élevé du marché »
- L’Afrique du Sud devrait enregistrer une forte croissance sur le marché de l’isolement et de la purification des acides nucléiques, grâce à des investissements croissants dans la recherche en biotechnologie et en sciences de la vie.
- En outre, l'adoption croissante de la médecine personnalisée en Afrique du Sud, conjuguée à la demande croissante de diagnostics moléculaires, contribue significativement à l'expansion du marché. L'essor des activités de recherche universitaire et clinique, notamment en génomique et en médecine de précision, renforce encore le besoin de technologies avancées d'isolement et de purification des acides nucléiques en Afrique du Sud.
- En outre, la présence de startups biotechnologiques émergentes et les collaborations avec des sociétés pharmaceutiques établies devraient favoriser davantage la croissance et l'innovation sur le marché sud-africain de l'isolement et de la purification des acides nucléiques.
Part de marché de l'isolement et de la purification des acides nucléiques
Le paysage concurrentiel du marché fournit des détails par concurrent. Il comprend la présentation de l'entreprise, ses données financières, son chiffre d'affaires, son potentiel de marché, ses investissements en recherche et développement, ses nouvelles initiatives commerciales, sa présence au Moyen-Orient et en Afrique, ses sites et installations de production, ses capacités de production, ses forces et faiblesses, le lancement de nouveaux produits, leur ampleur et leur portée, ainsi que la domination de ses applications. Les données ci-dessus ne concernent que les activités des entreprises par rapport à leur marché.
Les principaux leaders du marché opérant sur le marché sont :
- Thermo Fisher Scientific Inc. (États-Unis)
- Illumina Inc. (États-Unis)
- PerkinElmer (États-Unis)
- Meridian Bioscience, Inc. (États-Unis)
- QIAGEN (Afrique du Sud)
- Takara Bio Inc. (Japon)
- MACHEREY-NAGEL GmbH & Co. KG (Afrique du Sud)
- Lepu Medical Technology (Beijing) Co., Ltd. (Chine)
- Merck KGaA (Afrique du Sud)
- Cytiva (Danaher Corporation) (États-Unis)
- Agilent Technologies, Inc. (États-Unis)
- Bio-Rad Laboratories, Inc. (États-Unis)
- F. Hoffmann-La Roche SA (Suisse)
- KURABO INDUSTRIES LTD. (Japon)
- Analytik Jena GmbH+Co. KG (Afrique du Sud)
- TIANGEN BIOTECH (BEIJING) CO., LTD. (Chine)
Derniers développements dans l'isolement et la purification des acides nucléiques
- En avril 2025, Analytik Jena a lancé un nouveau plateau de 1536 pointes pour le CyBio Well vario, permettant le pipetage parallèle dans 1536 canaux avec des volumes allant de 100 nL à 8 µL. Cette innovation, idéale pour les applications à haut débit, garantit une grande précision, une consommation minimale de réactifs et favorise des flux de travail de laboratoire durables et reproductibles.
- En mars 2024, Analytik Jena a lancé la série multi N/C x300 d'analyseurs COT/TNb, offrant une conception conviviale, une automatisation flexible et un logiciel intuitif. Idéals pour les applications environnementales et pharmaceutiques, ces analyseurs garantissent un débit élevé, une grande fiabilité et de faibles coûts d'exploitation, permettant une préparation, un étalonnage et une maintenance efficaces des échantillons, avec une intégrité des données conforme aux normes pharmaceutiques.
SKU-
Accédez en ligne au rapport sur le premier cloud mondial de veille économique
- Tableau de bord d'analyse de données interactif
- Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
- Accès d'analyste de recherche pour la personnalisation et les requêtes
- Analyse de la concurrence avec tableau de bord interactif
- Dernières actualités, mises à jour et analyse des tendances
- Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Table des matières
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET
1.4 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.8 DBMR MARKET POSITION GRID
2.9 VENDOR SHARE ANALYSIS
2.1 MARKET END USER COVERAGE GRID
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHT
4.1 PORTER’S FIVE FORCES
4.2 PESTEL ANALYSIS
4.3 DEFINITION AND IMPORTANCE OF TARIFFS IN THE HEALTHCARE SECTOR
5 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: REGULATIONS
5.1 REGULATORY AUTHORITIES IN THE ASIA-PACIFIC REGION
5.2 NORTH AMERICA REGULATORY SCENARIO
5.3 EUROPE REGULATORY SCENARIO
5.4 REGULATORY SUBMISSIONS
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 INCREASING PREVALENCE OF GENETIC DISORDERS
6.1.2 INCREASING DEMAND FOR DIAGNOSTIC TESTING
6.1.3 RISING INVESTMENT IN GENOMICS RESEARCH
6.1.4 INCREASE IN LAUNCH OF DIAGNOSTIC PRODUCTS
6.2 RESTRAINTS
6.2.1 RISKS ASSOCIATED WITH SAMPLE CONTAMINATION
6.2.2 HIGH COST OF EQUIPMENT AND REAGENTS
6.3 OPPORTUNITIES
6.3.1 RISE IN TECHNOLOGICAL ADVANCEMENTS AND AUTOMATION
6.3.2 INCREASING ADOPTION OF NEXT-GENERATION SEQUENCING (NGS)
6.3.3 GROWING APPLICATIONS OF LIQUID BIOPSY IN NON-INVASIVE DIAGNOSTICS
6.4 CHALLENGES
6.4.1 TECHNICAL DIFFICULTIES IN NUCLEIC ACID ISOLATION ACROSS DIFFERENT SAMPLE TYPES
6.4.2 ENVIRONMENTAL AND SUSTAINABILITY CONCERNS
7 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE
7.1 OVERVIEW
7.2 NEXT GENERATION SEQUENCING (NGS)
7.3 GENOMIC DNA ISOLATION AND PURIFICATION
7.4 TOTAL RNA ISOLATION AND PURIFICATION
7.5 PCR CLEAN-UP
7.6 PLASMID DNA ISOLATION AND PURIFICATION
7.7 MESSENGER RNA ISOLATION AND PURIFICATION
7.8 CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION
7.9 MICRORNA ISOLATION AND PURIFICATION
7.1 OTHERS
8 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT
8.1 OVERVIEW
8.2 INSTRUMENTS
8.2.1 HOMOGENIZER
8.2.2 SPECTROPHOTOMETERS
8.2.3 FLUOROMETERS
8.2.4 OTHERS
8.2.4.1 BENCHTOP
8.2.4.2 STANDALONE
8.2.4.2.1 AUTOMATED
8.2.4.2.2 MANUAL
8.3 KITS
8.3.1 DNA ISOLATION & PURIFICATION KITS
8.3.2 RNA ISOLATION & PURIFICATION KITS
8.3.3 VIRAL NUCLEIC ACID ISOLATION KITS
8.3.4 PLASMID PURIFICATION KIT
8.3.5 PCR AND GEL KIT
8.3.6 OTHERS
8.3.6.1 MAGNETIC BEAD-BASED KIT
8.3.6.2 COLUMN-BASED KIT
8.3.6.3 REAGENT-BASED KIT
8.3.6.3.1 VIRAL/PATHOGEN NUCLEIC ACID ISOLATION KIT
8.3.6.3.2 PLANT DNA ISOLATION KIT
8.3.6.3.3 CELL-FREE TOTAL NUCLEIC ACID KIT
8.3.6.3.4 CELL-FREE DNA ISOLATION KIT
8.3.7 GENOMIC DNA PURIFICATION KIT
8.3.8 VIRAL RNA/DNA PURIFICATION KIT
8.3.9 PLANT DNA PURIFICATION KIT
8.3.10 MICROBIOME DNA PURIFICATION KIT
8.3.11 OTHERS
8.3.12 MAGNETIC BEAD-BASED KIT
8.3.13 COLUMN-BASED KIT
8.3.14 REAGENT-BASED KIT
8.3.15 VIRAL/PATHOGEN NUCLEIC ACID ISOLATION KIT
8.3.16 MRNA PURIFICATION KIT
8.3.17 PLANT RNA ISOLATION KIT
8.3.18 CELL-FREE NUCLEIC ACID ISOLATION KIT
8.3.19 OTHERS
8.3.20 RNA ISOLATION KIT
8.3.21 MI RNA ISOLATION KIT
8.3.22 VIRAL RNA/DNA KIT
8.3.23 MAGNETIC BEAD-BASED KITS
8.3.24 VIRAL SPIN-COLUMN KITS
8.4 REAGENTS
8.4.1 DNA ISOLATION REAGENT
8.4.2 RNA ISOLATION REAGENT
8.4.3 OTHERS
9 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE
9.1 OVERVIEW
9.2 FFPE SAMPLES
9.3 BLOOD CELLS
9.4 BACTERIA, YEAST, AND PLANTS
9.5 CELL-FREE SAMPLES
9.6 CULTURED CELLS
9.7 MAMMALIAN CELLS
9.8 BRAIN AND KIDNEY TISSUE
9.9 OTHERS
10 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD
10.1 OVERVIEW
10.2 MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION
10.3 COLUMN -BASED ISOLATION AND PURIFICATION
10.4 REAGENT-BASED ISOLATION AND PURIFICATION
10.5 OTHERS
11 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION
11.1 OVERVIEW
11.2 DIAGNOSTICS
11.2.1 INSTRUMENTS
11.2.2 KITS
11.2.3 REAGENTS
11.3 DRUG DISCOVERY AND DEVELOPMENT
11.3.1 INSTRUMENTS
11.3.2 KITS
11.3.3 REAGENTS
11.4 PERSONALIZED MEDICINE
11.4.1 INSTRUMENTS
11.4.2 KITS
11.4.3 REAGENTS
11.5 AGRICULTURE AND ANIMAL RESEARCH
11.5.1 INSTRUMENTS
11.5.2 KITS
11.5.3 REAGENTS
11.6 OTHERS
12 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER
12.1 OVERVIEW
12.2 HOSPITALS AND DIAGNOSTIC CENTERS
12.3 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
12.4 CONTRACT RESEARCH ORGANIZATIONS
12.5 CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION (CDMO)
12.6 ACADEMIC/RESEARCH INSTITUTES
12.7 OTHERS
13 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION
13.1 MIDDLE EAST AND AFRICA
13.1.1 SOUTH AFRICA
13.1.2 SAUDI ARABIA
13.1.3 U.A.E.
13.1.4 QATAR
13.1.5 EGYPT
13.1.6 KUWAIT
13.1.7 BAHRAIN
13.1.8 OMAN
13.1.9 REST OF MIDDLE EAST AND AFRICA
14 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA
15 SWOT ANALYSIS
16 COMPANY PROFILE
16.1 MERCK KGAA
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 COMPANY SHARE ANALYSIS
16.1.4 PRODUCT PORTFOLIO
16.1.5 RECENT DEVELOPMENT
16.2 CYTIVA (DANAHER CORPORATION)
16.2.1 COMPANY SNAPSHOT
16.2.2 REVENUE ANALYSIS
16.2.3 COMPANY SHARE ANALYSIS
16.2.4 PRODUCT PORTFOLIO
16.2.5 RECENT DEVELOPMENTS
16.3 AGILENT TECHNOLOGIES, INC.
16.3.1 COMPANY SNAPSHOT
16.3.2 REVENUE ANALYSIS
16.3.3 COMPANY SHARE ANALYSIS
16.3.4 PRODUCT PORTFOLIO
16.3.5 RECENT DEVELOPMENT
16.4 BIO-RAD LABORATORIES, INC.
16.4.1 COMPANY SNAPSHOT
16.4.2 REVENUE ANALYSIS
16.4.3 COMPANY SHARE ANALYSIS
16.4.4 PRODUCT PORTFOLIO
16.4.5 RECENT DEVELOPMENT
16.5 F. HOFFMANN-LA ROCHE LTD
16.5.1 COMPANY SNAPSHOT
16.5.2 REVENUE ANALYSIS
16.5.3 COMPANY SHARE ANALYSIS
16.5.4 PRODUCT PORTFOLIO
16.5.5 RECENT DEVELOPMENT
16.6 ANALYTIK JENA GMBH+CO. KG
16.6.1 COMPANY SNAPSHOT
16.6.2 PRODUCT PORTFOLIO
16.6.3 RECENT DEVELOPMENT
16.7 AUTOGEN, INC.
16.7.1 COMPANY SNAPSHOT
16.7.2 PRODUCT PORTFOLIO
16.7.3 RECENT DEVELOPMENT
16.8 DAAN GENE CO., LTD.
16.8.1 COMPANY SNAPSHOT
16.8.2 PRODUCT PORTFOLIO
16.8.3 RECENT DEVELOPMENT
16.9 HIMEDIA LABORATORIES
16.9.1 COMPANY SNAPSHOT
16.9.2 PRODUCT PORTFOLIO
16.9.3 RECENT DEVELOPMENT
16.1 ILLUMINA, INC.
16.10.1 COMPANY SNAPSHOT
16.10.2 REVENUE ANALYSIS
16.10.3 PRODUCT PORTFOLIO
16.10.4 RECENT DEVELOPMENT
16.11 KURABO INDUSTRIES LTD.
16.11.1 COMPANY SNAPSHOT
16.11.2 REVENUE ANALYSIS
16.11.3 PRODUCT PORTFOLIO
16.11.4 RECENT DEVELOPMENT
16.12 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.
16.12.1 COMPANY SNAPSHOT
16.12.2 REVENUE ANALYSIS
16.12.3 PRODUCT PORTFOLIO
16.12.4 RECENT DEVELOPMENT
16.13 LGC BIOSEARCH TECHNOLOGIES
16.13.1 COMPANY SNAPSHOT
16.13.2 PRODUCT PORTFOLIO
16.13.3 RECENT DEVELOPMENTS
16.14 MACHEREY-NAGEL GMBH & CO. KG
16.14.1 COMPANY SNAPSHOT
16.14.2 PRODUCT PORTFOLIO
16.14.3 RECENT DEVELOPMENT
16.15 MAGGENOME TECHNOLOGIES PVT. LTD.
16.15.1 COMPANY SNAPSHOT
16.15.2 PRODUCT PORTFOLIO
16.15.3 RECENT DEVELOPMENT
16.16 MEDOX BIOTECH INDIA PVT. LTD.
16.16.1 COMPANY SNAPSHOT
16.16.2 PRODUCT PORTFOLIO
16.16.3 RECENT DEVELOPMENT
16.17 MERIDIAN BIOSCIENCE, INC.
16.17.1 COMPANY SNAPSHOT
16.17.2 PRODUCT PORTFOLIO
16.17.3 RECENT DEVELOPMENT
16.18 NEW ENGLAND BIOLABS
16.18.1 COMPANY SNAPSHOT
16.18.2 PRODUCT PORTFOLIO
16.18.3 RECENT DEVELOPMENT
16.19 NORGEN BIOTEK CORP.
16.19.1 COMPANY SNAPSHOT
16.19.2 PRODUCT PORTFOLIO
16.19.3 RECENT DEVELOPMENT
16.2 OMEGA BIO-TEK, INC.
16.20.1 COMPANY SNAPSHOT
16.20.2 PRODUCT PORTFOLIO
16.20.3 RECENT DEVELOPMENT
16.21 PCR BIOSYSTEMS
16.21.1 COMPANY SNAPSHOT
16.21.2 PRODUCT PORTFOLIO
16.21.3 RECENT DEVELOPMENT
16.22 PERKINELMER
16.22.1 COMPANY SNAPSHOT
16.22.2 REVENUE ANALYSIS
16.22.3 PRODUCT PORTFOLIO
16.22.4 RECENT DEVELOPMENT
16.23 PROMEGA CORPORATION
16.23.1 COMPANY SNAPSHOT
16.23.2 PRODUCT PORTFOLIO
16.23.3 RECENT DEVELOPMENT
16.24 QIAGEN
16.24.1 COMPANY SNAPSHOT
16.24.2 REVENUE ANALYSIS
16.24.3 PRODUCT PORTFOLIO
16.24.4 RECENT DEVELOPMENTS/NEWS
16.25 SAGE SCIENCE, INC.
16.25.1 COMPANY SNAPSHOT
16.25.2 PRODUCT PORTFOLIO
16.25.3 RECENT DEVELOPMENTS
16.26 TAKARA BIO INC.
16.26.1 COMPANY SNAPSHOT
16.26.2 REVENUE ANALYSIS
16.26.3 PRODUCT PORTFOLIO
16.26.4 RECENT DEVELOPMENTS
16.27 THERMO FISHER SCIENTIFIC INC.
16.27.1 COMPANY SNAPSHOT
16.27.2 REVENUE ANALYSIS
16.27.3 PRODUCT PORTFOLIO
16.27.4 RECENT DEVELOPMENT
16.28 TIANGEN BIOTECH (BEIJING) CO.,LTD.
16.28.1 COMPANY SNAPSHOT
16.28.2 PRODUCT PORTFOLIO
16.28.3 RECENT DEVELOPMENT
16.29 XI'AN TIANLONG SCIENCE AND TECHNOLOGY CO., LTD
16.29.1 COMPANY SNAPSHOT
16.29.2 PRODUCT PORTFOLIO
16.29.3 RECENT DEVELOPMENT
16.3 ZYMO RESEARCH CORPORATION
16.30.1 COMPANY SNAPSHOT
16.30.2 PRODUCT PORTFOLIO
16.30.3 RECENT DEVELOPMENT
17 QUESTIONNAIRE
18 RELATED REPORTS
Liste des tableaux
TABLE 1 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 2 MIDDLE EAST AND AFRICA NEXT GENERATION SEQUENCING (NGS) IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 3 MIDDLE EAST AND AFRICA GENOMIC DNA ISOLATION AND PURIFICATION IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 4 MIDDLE EAST AND AFRICA TOTAL RNA ISOLATION AND PURIFICATION IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 5 MIDDLE EAST AND AFRICA PCR CLEAN-UP IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 6 MIDDLE EAST AND AFRICA PLASMID DNA ISOLATION AND PURIFICATION IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 7 MIDDLE EAST AND AFRICA MESSENGER RNA ISOLATION AND PURIFICATION IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 8 MIDDLE EAST AND AFRICA CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 9 MIDDLE EAST AND AFRICA MICRORNA ISOLATION AND PURIFICATION IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 10 MIDDLE EAST AND AFRICA OTHERS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 11 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)
TABLE 12 MIDDLE EAST AND AFRICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 13 MIDDLE EAST AND AFRICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 14 MIDDLE EAST AND AFRICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 15 MIDDLE EAST AND AFRICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 16 MIDDLE EAST AND AFRICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 17 MIDDLE EAST AND AFRICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY USABILITY, 2018-2032 (USD THOUSAND)
TABLE 18 MIDDLE EAST AND AFRICA KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 19 MIDDLE EAST AND AFRICA KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 20 MIDDLE EAST AND AFRICA DNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 21 MIDDLE EAST AND AFRICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 22 MIDDLE EAST AND AFRICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 23 MIDDLE EAST AND AFRICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 24 MIDDLE EAST AND AFRICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 25 MIDDLE EAST AND AFRICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 26 MIDDLE EAST AND AFRICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 27 MIDDLE EAST AND AFRICA RNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 28 MIDDLE EAST AND AFRICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 29 MIDDLE EAST AND AFRICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 30 MIDDLE EAST AND AFRICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 31 MIDDLE EAST AND AFRICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 32 MIDDLE EAST AND AFRICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 33 MIDDLE EAST AND AFRICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 34 MIDDLE EAST AND AFRICA VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 35 MIDDLE EAST AND AFRICA VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 36 MIDDLE EAST AND AFRICA VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 37 MIDDLE EAST AND AFRICA REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 38 MIDDLE EAST AND AFRICA REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 39 MIDDLE EAST AND AFRICA REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 40 MIDDLE EAST AND AFRICA REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 41 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)
TABLE 42 MIDDLE EAST AND AFRICA FFPE SAMPLES IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 43 MIDDLE EAST AND AFRICA BLOOD CELLS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 44 MIDDLE EAST AND AFRICA BACTERIA, YEAST, AND PLANTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 45 MIDDLE EAST AND AFRICA CELL-FREE SAMPLES IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 46 MIDDLE EAST AND AFRICA CULTURED CELLS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 47 MIDDLE EAST AND AFRICA MAMMALIAN CELLS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 48 MIDDLE EAST AND AFRICA BRAIN AND KIDNEY TISSUE IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 49 MIDDLE EAST AND AFRICA OTHERS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 50 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2032 (USD THOUSAND)
TABLE 51 MIDDLE EAST AND AFRICA MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 52 MIDDLE EAST AND AFRICA COLUMN-BASED ISOLATION AND PURIFICATION IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 53 MIDDLE EAST AND AFRICA REAGENT-BASED ISOLATION AND PURIFICATION IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 54 MIDDLE EAST AND AFRICA OTHERS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 55 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 56 MIDDLE EAST AND AFRICA DIAGNOSTICS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 57 MIDDLE EAST AND AFRICA DIAGNOSTICS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 58 MIDDLE EAST AND AFRICA DRUG DISCOVERY AND DEVELOPMENT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 59 MIDDLE EAST AND AFRICA DRUG DISCOVERY AND DEVELOPMENT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 60 MIDDLE EAST AND AFRICA PERSONALIZED MEDICINE IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 61 MIDDLE EAST AND AFRICA PERSONALIZED MEDICINE IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 62 MIDDLE EAST AND AFRICA AGRICULTURE AND ANIMAL RESEARCH IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 63 MIDDLE EAST AND AFRICA AGRICULTURE AND ANIMAL RESEARCH IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 64 MIDDLE EAST AND AFRICA OTHERS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 65 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 66 MIDDLE EAST AND AFRICA HOSPITALS AND DIAGNOSTIC CENTERS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 67 MIDDLE EAST AND AFRICA PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 68 MIDDLE EAST AND AFRICA CONTRACT RESEARCH ORGANIZATIONS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 69 MIDDLE EAST AND AFRICA CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION (CDMO) IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 70 MIDDLE EAST AND AFRICA ACADEMIC/RESEARCH INSTITUTES IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 71 MIDDLE EAST AND AFRICA OTHERS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 72 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2018-2032 (USD THOUSAND)
TABLE 73 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)
TABLE 74 MIDDLE EAST AND AFRICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 75 MIDDLE EAST AND AFRICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 76 MIDDLE EAST AND AFRICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 77 MIDDLE EAST AND AFRICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 78 MIDDLE EAST AND AFRICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY USABILITY, 2018-2032 (USD THOUSAND)
TABLE 79 MIDDLE EAST AND AFRICA KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 80 MIDDLE EAST AND AFRICA DNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 81 MIDDLE EAST AND AFRICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 82 MIDDLE EAST AND AFRICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 83 MIDDLE EAST AND AFRICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 84 MIDDLE EAST AND AFRICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 85 MIDDLE EAST AND AFRICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 86 MIDDLE EAST AND AFRICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 87 MIDDLE EAST AND AFRICA RNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 88 MIDDLE EAST AND AFRICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 89 MIDDLE EAST AND AFRICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 90 MIDDLE EAST AND AFRICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 91 MIDDLE EAST AND AFRICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 92 MIDDLE EAST AND AFRICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 93 MIDDLE EAST AND AFRICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 94 MIDDLE EAST AND AFRICA VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 95 MIDDLE EAST AND AFRICA VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 96 MIDDLE EAST AND AFRICA VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 97 MIDDLE EAST AND AFRICA REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 98 MIDDLE EAST AND AFRICA REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 99 MIDDLE EAST AND AFRICA REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 100 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2032 (USD THOUSAND)
TABLE 101 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 102 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 103 MIDDLE EAST AND AFRICA DIAGNOSTICS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 104 MIDDLE EAST AND AFRICA DRUG DISCOVERY AND DEVELOPMENT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 105 MIDDLE EAST AND AFRICA PERSONALIZED MEDICINE IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 106 MIDDLE EAST AND AFRICA AGRICULTURE AND ANIMAL RESEARCH IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 107 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)
TABLE 108 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 109 SOUTH AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)
TABLE 110 SOUTH AFRICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 111 SOUTH AFRICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 112 SOUTH AFRICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 113 SOUTH AFRICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 114 SOUTH AFRICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY USABILITY, 2018-2032 (USD THOUSAND)
TABLE 115 SOUTH AFRICA KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 116 SOUTH AFRICA DNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 117 SOUTH AFRICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 118 SOUTH AFRICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 119 SOUTH AFRICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 120 SOUTH AFRICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 121 SOUTH AFRICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 122 SOUTH AFRICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 123 SOUTH AFRICA RNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 124 SOUTH AFRICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 125 SOUTH AFRICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 126 SOUTH AFRICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 127 SOUTH AFRICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 128 SOUTH AFRICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 129 SOUTH AFRICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 130 SOUTH AFRICA VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 131 SOUTH AFRICA VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 132 SOUTH AFRICA VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 133 SOUTH AFRICA REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 134 SOUTH AFRICA REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 135 SOUTH AFRICA REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 136 SOUTH AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2032 (USD THOUSAND)
TABLE 137 SOUTH AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 138 SOUTH AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 139 SOUTH AFRICA DIAGNOSTICS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 140 SOUTH AFRICA DRUG DISCOVERY AND DEVELOPMENT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 141 SOUTH AFRICA PERSONALIZED MEDICINE IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 142 SOUTH AFRICA AGRICULTURE AND ANIMAL RESEARCH IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 143 SOUTH AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)
TABLE 144 SOUTH AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 145 SAUDI ARABIA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)
TABLE 146 SAUDI ARABIA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 147 SAUDI ARABIA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 148 SAUDI ARABIA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 149 SAUDI ARABIA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 150 SAUDI ARABIA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY USABILITY, 2018-2032 (USD THOUSAND)
TABLE 151 SAUDI ARABIA KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 152 SAUDI ARABIA DNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 153 SAUDI ARABIA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 154 SAUDI ARABIA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 155 SAUDI ARABIA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 156 SAUDI ARABIA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 157 SAUDI ARABIA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 158 SAUDI ARABIA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 159 SAUDI ARABIA RNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 160 SAUDI ARABIA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 161 SAUDI ARABIA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 162 SAUDI ARABIA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 163 SAUDI ARABIA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 164 SAUDI ARABIA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 165 SAUDI ARABIA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 166 SAUDI ARABIA VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 167 SAUDI ARABIA VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 168 SAUDI ARABIA VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 169 SAUDI ARABIA REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 170 SAUDI ARABIA REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 171 SAUDI ARABIA REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 172 SAUDI ARABIA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2032 (USD THOUSAND)
TABLE 173 SAUDI ARABIA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 174 SAUDI ARABIA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 175 SAUDI ARABIA DIAGNOSTICS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 176 SAUDI ARABIA DRUG DISCOVERY AND DEVELOPMENT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 177 SAUDI ARABIA PERSONALIZED MEDICINE IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 178 SAUDI ARABIA AGRICULTURE AND ANIMAL RESEARCH IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 179 SAUDI ARABIA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)
TABLE 180 SAUDI ARABIA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 181 U.A.E. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)
TABLE 182 U.A.E. INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 183 U.A.E. INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 184 U.A.E. INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 185 U.A.E. INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 186 U.A.E. INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY USABILITY, 2018-2032 (USD THOUSAND)
TABLE 187 U.A.E. KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 188 U.A.E. DNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 189 U.A.E. MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 190 U.A.E. MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 191 U.A.E. MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 192 U.A.E. COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 193 U.A.E. COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 194 U.A.E. COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 195 U.A.E. RNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 196 U.A.E. MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 197 U.A.E. MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 198 U.A.E. MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 199 U.A.E. COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 200 U.A.E. COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 201 U.A.E. COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 202 U.A.E. VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 203 U.A.E. VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 204 U.A.E. VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 205 U.A.E. REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 206 U.A.E. REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 207 U.A.E. REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 208 U.A.E. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2032 (USD THOUSAND)
TABLE 209 U.A.E. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 210 U.A.E. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 211 U.A.E. DIAGNOSTICS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 212 U.A.E. DRUG DISCOVERY AND DEVELOPMENT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 213 U.A.E. PERSONALIZED MEDICINE IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 214 U.A.E. AGRICULTURE AND ANIMAL RESEARCH IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 215 U.A.E. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)
TABLE 216 U.A.E. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 217 QATAR NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)
TABLE 218 QATAR INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 219 QATAR INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 220 QATAR INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 221 QATAR INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 222 QATAR INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY USABILITY, 2018-2032 (USD THOUSAND)
TABLE 223 QATAR KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 224 QATAR DNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 225 QATAR MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 226 QATAR MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 227 QATAR MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 228 QATAR COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 229 QATAR COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 230 QATAR COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 231 QATAR RNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 232 QATAR MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 233 QATAR MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 234 QATAR MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 235 QATAR COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 236 QATAR COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 237 QATAR COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 238 QATAR VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 239 QATAR VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 240 QATAR VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 241 QATAR REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 242 QATAR REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 243 QATAR REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 244 QATAR NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2032 (USD THOUSAND)
TABLE 245 QATAR NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 246 QATAR NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 247 QATAR DIAGNOSTICS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 248 QATAR DRUG DISCOVERY AND DEVELOPMENT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 249 QATAR PERSONALIZED MEDICINE IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 250 QATAR AGRICULTURE AND ANIMAL RESEARCH IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 251 QATAR NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)
TABLE 252 QATAR NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 253 EGYPT NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)
TABLE 254 EGYPT INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 255 EGYPT INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 256 EGYPT INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 257 EGYPT INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 258 EGYPT INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY USABILITY, 2018-2032 (USD THOUSAND)
TABLE 259 EGYPT KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 260 EGYPT DNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 261 EGYPT MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 262 EGYPT MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 263 EGYPT MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 264 EGYPT COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 265 EGYPT COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 266 EGYPT COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 267 EGYPT RNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 268 EGYPT MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 269 EGYPT MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 270 EGYPT MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 271 EGYPT COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 272 EGYPT COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 273 EGYPT COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 274 EGYPT VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 275 EGYPT VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 276 EGYPT VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 277 EGYPT REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 278 EGYPT REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 279 EGYPT REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 280 EGYPT NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2032 (USD THOUSAND)
TABLE 281 EGYPT NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 282 EGYPT NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 283 EGYPT DIAGNOSTICS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 284 EGYPT DRUG DISCOVERY AND DEVELOPMENT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 285 EGYPT PERSONALIZED MEDICINE IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 286 EGYPT AGRICULTURE AND ANIMAL RESEARCH IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 287 EGYPT NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)
TABLE 288 EGYPT NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 289 KUWAIT NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)
TABLE 290 KUWAIT INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 291 KUWAIT INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 292 KUWAIT INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 293 KUWAIT INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 294 KUWAIT INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY USABILITY, 2018-2032 (USD THOUSAND)
TABLE 295 KUWAIT KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 296 KUWAIT DNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 297 KUWAIT MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 298 KUWAIT MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 299 KUWAIT MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 300 KUWAIT COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 301 KUWAIT COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 302 KUWAIT COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 303 KUWAIT RNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 304 KUWAIT MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 305 KUWAIT MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 306 KUWAIT MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 307 KUWAIT COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 308 KUWAIT COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 309 KUWAIT COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 310 KUWAIT VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 311 KUWAIT VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 312 KUWAIT VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 313 KUWAIT REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 314 KUWAIT REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 315 KUWAIT REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 316 KUWAIT NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2032 (USD THOUSAND)
TABLE 317 KUWAIT NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 318 KUWAIT NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 319 KUWAIT DIAGNOSTICS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 320 KUWAIT DRUG DISCOVERY AND DEVELOPMENT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 321 KUWAIT PERSONALIZED MEDICINE IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 322 KUWAIT AGRICULTURE AND ANIMAL RESEARCH IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 323 KUWAIT NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)
TABLE 324 KUWAIT NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 325 BAHRAIN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)
TABLE 326 BAHRAIN INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 327 BAHRAIN INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 328 BAHRAIN INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 329 BAHRAIN INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 330 BAHRAIN INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY USABILITY, 2018-2032 (USD THOUSAND)
TABLE 331 BAHRAIN KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 332 BAHRAIN DNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 333 BAHRAIN MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 334 BAHRAIN MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 335 BAHRAIN MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 336 BAHRAIN COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 337 BAHRAIN COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 338 BAHRAIN COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 339 BAHRAIN RNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 340 BAHRAIN MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 341 BAHRAIN MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 342 BAHRAIN MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 343 BAHRAIN COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 344 BAHRAIN COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 345 BAHRAIN COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 346 BAHRAIN VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 347 BAHRAIN VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 348 BAHRAIN VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 349 BAHRAIN REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 350 BAHRAIN REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 351 BAHRAIN REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 352 BAHRAIN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2032 (USD THOUSAND)
TABLE 353 BAHRAIN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 354 BAHRAIN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 355 BAHRAIN DIAGNOSTICS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 356 BAHRAIN DRUG DISCOVERY AND DEVELOPMENT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 357 BAHRAIN PERSONALIZED MEDICINE IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 358 BAHRAIN AGRICULTURE AND ANIMAL RESEARCH IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 359 BAHRAIN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)
TABLE 360 BAHRAIN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 361 OMAN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)
TABLE 362 OMAN INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 363 OMAN INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 364 OMAN INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 365 OMAN INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 366 OMAN INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY USABILITY, 2018-2032 (USD THOUSAND)
TABLE 367 OMAN KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 368 OMAN DNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 369 OMAN MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 370 OMAN MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 371 OMAN MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 372 OMAN COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 373 OMAN COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 374 OMAN COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 375 OMAN RNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 376 OMAN MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 377 OMAN MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 378 OMAN MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 379 OMAN COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 380 OMAN COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 381 OMAN COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 382 OMAN VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 383 OMAN VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 384 OMAN VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 385 OMAN REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 386 OMAN REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 387 OMAN REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 388 OMAN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2032 (USD THOUSAND)
TABLE 389 OMAN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 390 OMAN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 391 OMAN DIAGNOSTICS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 392 OMAN DRUG DISCOVERY AND DEVELOPMENT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 393 OMAN PERSONALIZED MEDICINE IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 394 OMAN AGRICULTURE AND ANIMAL RESEARCH IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 395 OMAN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)
TABLE 396 OMAN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 397 REST OF MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)
Liste des figures
FIGURE 1 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: DATA TRIANGULATION
FIGURE 3 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: MIDDLE EAST AND AFRICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: MULTIVARIATE MODELLING
FIGURE 7 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: DBMR MARKET POSITION GRID
FIGURE 9 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: MARKET END USER COVERAGE GRID
FIGURE 11 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: SEGMENTATION
FIGURE 12 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: EXECUTIVE SUMMARY
FIGURE 13 STRATEGIC DECISIONS
FIGURE 14 LINE CHART, BY PRODUCT (2024)
FIGURE 15 THREE SEGMENTS COMPRISE THE MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT (2024)
FIGURE 16 INCREASING PREVALENCE OF GENETIC DISORDERS IS EXPECTED TO DRIVE THE MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET IN THE FORECAST PERIOD (2025-2032)
FIGURE 17 INSTRUMENTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET IN 2025 & 2032
FIGURE 18 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES FOR MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET
FIGURE 19 DISTRIBUTION OF REPORTED GENETIC CONDITIONS AMONG CHILDREN BY AGE GROUP (AGES 0–17)
FIGURE 20 DISTRIBUTION OF REPORTED GENETIC CONDITIONS AMONG CHILDREN BY GENDER
FIGURE 21 DISTRIBUTION OF REPORTED GENETIC CONDITIONS AMONG CHILDREN BY RACE AND ETHNICITY
FIGURE 22 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY TYPE, 2024
FIGURE 23 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY TYPE, 2025-2032 (USD THOUSAND)
FIGURE 24 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY TYPE, CAGR (2025-2032)
FIGURE 25 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY TYPE, LIFELINE CURVE
FIGURE 26 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY PRODUCT, 2024
FIGURE 27 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY PRODUCT, 2025-2032 (USD THOUSAND)
FIGURE 28 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY PRODUCT, CAGR (2025-2032)
FIGURE 29 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 30 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY SAMPLE TYPE, 2024
FIGURE 31 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY SAMPLE TYPE, 2025-2032 (USD THOUSAND)
FIGURE 32 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY SAMPLE TYPE, CAGR (2025-2032)
FIGURE 33 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY SAMPLE TYPE, LIFELINE CURVE
FIGURE 34 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY METHOD, 2024
FIGURE 35 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY METHOD, 2025-2032 (USD THOUSAND)
FIGURE 36 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY METHOD, CAGR (2025-2032)
FIGURE 37 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY METHOD, LIFELINE CURVE
FIGURE 38 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY APPLICATION, 2024
FIGURE 39 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY APPLICATION, 2025-2032 (USD THOUSAND)
FIGURE 40 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY APPLICATION, CAGR (2025-2032)
FIGURE 41 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 42 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY END USER, 2024
FIGURE 43 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY END USER, 2025-2032 (USD THOUSAND)
FIGURE 44 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY END USER, CAGR (2025-2032)
FIGURE 45 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY END USER, LIFELINE CURVE
FIGURE 46 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: SNAPSHOT (2024)
FIGURE 47 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: COMPANY SHARE 2024 (%)
Méthodologie de recherche
La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.
La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.
Personnalisation disponible
Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.
